ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Aurobindo Pharma has scheduled a Board Meeting for August 5, 2026, to consider and approve its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.
Aurobindo Pharma scheduled a board meeting on May 21, 2026, to approve fiscal 2026 financial results. The trading window remains closed until May 23, 2026.